Actin Cytoskeleton Remodeling Drives Epithelial-Mesenchymal Transition for Hepatoma Invasion and Metastasis

Hepatology - United States
doi 10.1002/hep.29678
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

ASPP1 Deficiency Promotes Epithelial-Mesenchymal Transition, Invasion and Metastasis in Colorectal Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

The Role of Epithelial–mesenchymal Transition Programming in Invasion and Metastasis: A Clinical Perspective

Cancer Management and Research
Oncology
2013English

Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis

Cancer Research
Cancer ResearchOncology
2009English

Actin-Like 6A Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Metastasis and Epithelial-Mesenchymal Transition

Hepatology
MedicineHepatology
2016English

BRD7 Suppresses Invasion and Metastasis in Breast Cancer by Negatively Regulating YB1-induced Epithelial-Mesenchymal Transition

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2020English

Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition

Cancer Management and Research
Oncology
2020English

JARID2 Promotes Invasion and Metastasis of Hepatocellular Carcinoma by Facilitating Epithelial-Mesenchymal Transition Through PTEN/AKT Signaling

Oncotarget
Oncology
2016English

TRIM37 Promotes Cell Invasion and Metastasis by Regulating SIP1-mediated Epithelial–mesenchymal Transition in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy